All In MedTech

Device Trial Radar · NCT02412163

Ellipse Intramedullary Nail High Tibial Osteotomy Study

A Multicenter Study of Patients Treated With the Ellipse Technologies Intramedullary High Tibial Osteotomy (IM HTO) Nail System for Osteoarthritis and Varus Malalignment of the Knee

Last checked: Nov 20, 2026Latest source record: Sep 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

41

Actual

Start

Jul 2015

Primary completion

Jul 2015

Study completion Dec 2016

Sponsor

Lead sponsor
Ellipse Technologies, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 9, 2015

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study further evaluates the safety profile and efficacy of the Ellipse IM HTO Nail system in subjects with osteoarthritis and varus malalignment of the knee. All subjects will receive treatment with the Ellipse IM HTO Nail System and followed for six months.

Conditions

  • Osteoarthritis
  • Varus Malalignment

Interventions

  • Ellipse IM HTO NailDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Weight-Bearing Line at Final Correction within ±5, 10, and 15% of Baseline TargetTime frame: Pre-Op, Week 6 (Considered the Final Correction Visit unless additional visits are required)

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • Medizinische Hochschule

    Hanover, Germany

  • Martini Ziekenhuis

    Groningen, Netherlands

  • Isala Klinieken

    Zwolle, Netherlands

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.